Full name
MOLLUSAN EUROPE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
70.10.Z - Head office activities
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.91.Z - Intermediary retail sale, non-specialized
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -6,8 | -44,7 | -77,4 | -73,1 |
EBITDA | -6,8 | -14,2 | -77,4 | -445,1 |
Short time liabilities | 6,3 | 256,2 | 305,6 | 19,3 |
Equity capital | -3,4 | -48,1 | -125,5 | -160,9 |
Operating profit (EBIT) | -6,8 | -44,7 | -77,4 | -73,2 |
Assets | 2,9 | 208,1 | 180,1 | -13,4 |
Net profit (loss) | -6,8 | -44,7 | -77,4 | -73,1 |
Cash | 1,9 | 2,4 | 14 | 489,6 |
Liabilities and provisions for liabilities | 6,3 | 256,2 | 305,6 | 19,3 |
Net income from sale | 0 | 22 | 23 | 4,5 |
Working assets | 1,9 | 86,1 | 88,6 | 3 |
Depreciation | 0 | 30,5 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 199,2 | 92,9 | 61,7 | -31,2 |
Equity capital to total assets | -116,2 | -23,1 | -69,7 | -46,6 |
Gross profit margin | -203,3 | -336,7 | -133,4 | |
EBITDA Margin | -64,6 | -336,7 | -272,1 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 4252 | 4853 | 601 |
Current financial liquidity indicator | 0.3046819269657135 | 0.33604541420936584 | 0.2900574505329132 | 0 |
Net dept to EBITDA | 0.2845584452152252 | -17.794902801513672 | -3.760103940963745 | 14 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane